Anika Therapeutics | ANIK - DEUDA





DEUDA Cambio Fecha
Abbott USD 12.94B 496M 2025-09
Agenus USD 35.54M 2.34M 2025-03
Agios Pharmaceuticals USD 44.52M 4.24M 2025-09
Anika Therapeutics USD 0 0 2025-03
Arrowhead Research USD 366.28M 13.25M 2025-09
Enanta Pharmaceuticals USD 1.35M 0 2024-12
Halozyme Therapeutics USD 1.51B 1.66M 2025-09
Heron Therapeutics USD 149.65M 157K 2024-09
Insmed USD 727.89M 163.33M 2025-12
Integra LifeSciences USD 2.01B 7.91M 2025-09
Intrexon USD 0 13.82M 2024-06
J&J USD 45.8B 4.97B 2025-09
Karyopharm Therapeutics USD 264.09M 39.31M 2024-09
Ligand Pharmaceuticals USD 451M 445.26M 2025-09
MacroGenics USD 37.01M 238K 2025-09
Merit Medical Systems USD 821.15M 599K 2025-09
Rigel Pharmaceuticals USD 59.69M 90K 2024-06
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 21.76B 530M 2025-09
Smith & Nephew USD 3.32B 334M 2024-12
Stryker USD 14.86B 1.74B 2025-12
Surmodics USD 29.55M 111K 2024-09
Veracyte USD 40.45M 10.19M 2025-09
Xencor USD 69.27M 1.34M 2025-09
Zimmer Biomet Holdings USD 7.52B 593.5M 2025-12